Pregabalin

From WikiMD's WELLNESSPEDIA

(Redirected from Lyrica CR)

Information about Pregabalin[edit]

Pregabalin is an inhibitor of neuronal activity used for therapy of neuropathy and as an anticonvulsant. 

File:Pregabalin Structural Formulae.png
Pregabalin Structural Formulae
File:Lyrica lääkepakkauksia.JPG
Lyrica lääkepakkauksia


Liver safety of Pregabalin[edit]

Therapy with pregabalin is not associated with serum aminotransferase elevations, and clinically apparent liver injury from pregabalin has been reported but appears to be quite rare. 


Mechanism of action of Pregabalin[edit]

Pregabalin (pre gab' a lin) is a structural analogue of gamma-aminobutyric acid (GABA) but is novel in its activity, having no effects on GABA-A or GABA-B receptors.  Instead, the neuronal acitivity of pregabalin appears to be mediated by its binding to the alpha-2-delta subunit of the presynaptic voltage-gated calcium channel whcih leads to a decrease in release of neuroexcitatory neurotransmitters by hyperexcited neurons.  Pregabalin has been shown to be effective in reducing neuropathic pain from diabetic and postherpetic neuropathy and is an effective anticonvulsant. 

FDA approval information for Pregabalin[edit]

Pregabalin was approved for use in the United States in 2004.  Current indications include diabetic and post-herpetic neuropathy and as adjunctive therapy of partial onset seizures.  Pregabalin is also used for fibromyalgia and off-label for generalized anxiety disorders and migraine.

Dosage and administration for Pregabalin[edit]

Pregabalin is available in capsules in varying concentrations from 25 to 300 mg under the brand name of Lyrica.  The recommended initial dose for neuropathic pain is 50 to 75 mg two to three times daily, the maximum dose being 300 mg daily.  Higher doses are used in treating seizures. The dose should be increased and tapered gradually. 

Side effects of Pregabalin[edit]

The most common side effects of pregabalin are dose related and include peripheral edema, weight gain, dizziness, somnolence, confusion, headache, blurred vision, tremor and ataxia.



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.